Investors are contemplating opportunities in the stock market, particularly for the long term. While attempting to achieve substantial returns within six months to a year can be risky, a decade-long horizon provides a more reliable outlook for equity performance. With a careful selection of stocks, investors may even see above-average returns over this period.
Two companies garnering attention for their recent strong performances are Robinhood Markets and HCA Healthcare. Analysts believe both have potential for competitive returns leading into 2036, with distinct characteristics and market positions.
Robinhood Markets has made a name for itself as a pioneering investment app that popularized commission-free trading. Over the past couple of years, the company has experienced impressive growth, with both revenue and earnings seeing significant increases. However, questions linger about its ability to sustain this momentum over the next decade. With a forward price-to-earnings ratio of 46.5, Robinhood appears expensive compared to the industry average of 16.5 for financial stocks.
A crucial factor in Robinhood’s business is its dependence on cryptocurrency trading, which constitutes a substantial and fluctuating share of its revenues. The volatile nature of the crypto market introduces uncertainty, and any decrease in trading volume could negatively impact earnings. However, the company retains strong prospects due to its appeal among younger investors. Its modern platform, featuring commission-free trading, fractional shares, and social media-like elements, resonates with millennial and Gen Z audiences, who are more inclined to invest in cryptocurrencies.
In recent months, Robinhood has expanded its services by launching advanced trading tools and features, such as the Robinhood Legend platform and AI-driven trading resources. Their subscription service, Robinhood Gold, has also seen increasing user adoption, providing a steady stream of high-margin revenue. For investors willing to hold onto the stock for a decade, the current valuation may justify the purchase.
HCA Healthcare stands to gain from an aging population in the United States. Projections suggest that by 2035, older adults aged 65 and up will outnumber children aged 18 and younger. This demographic shift, fueled by longer life expectancies due to medical advancements and declining birth rates, is expected to drive significant increases in healthcare spending, benefiting companies like HCA.
HCA operates a broad network of healthcare facilities across the U.S. and the UK, including urgent care centers, hospitals, and surgery centers. The company has shown solid performance recently, attributed to heightened demand for medical services and favorable reimbursement rates. Currently, the stock shows a modest dividend yield of 0.61%, providing further incentives for investors.
However, HCA faces challenges due to the complexities of reimbursement, especially with changes to Medicare and Medicaid. The company manages these risks with a diverse payer mix, as roughly half of its revenue derives from commercial insurance, which typically offers higher reimbursement rates. Additionally, HCA invests heavily in advanced technology to enhance patient care and attract insurance payers, positioning itself for continued market share growth.
Both Robinhood Markets and HCA Healthcare present intriguing opportunities for long-term investors. Their distinct business models and market positions suggest that with the right investment strategy, these stocks may generate refined returns over the next decade.
